Biotech / Medical | Provectus Pharmaceuticals Inc.


Previous 10 | Next 10 
To: TheMaster who wrote (9411)8/19/2011 12:56:05 PM
From: Mark Buczynski   of 11958
 
When you argue with idiots, you immediately denigrate yourself and stoop to their level.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: Littlebits who wrote (9406)8/19/2011 4:01:23 PM
From: NTTG2 Recommendations   of 11958
 
The comment is in reference to the former company this MGT crew use to run, you know...the one that went BK. In those days they were using RB as a laser active agent, most of the original tissue culture work was from that era. They still quote the in-vitro data today, but just dont do the laser part on people. You can still read the data in current Patent applications and reports from analysts who suggest $3.0 SP in the near future....but that really is not how the current studies are done:
clinicaltrials.gov 

clinicaltrials.gov 

clinicaltrials.gov 

The one time, long ago now, they tried laser + PH 10 they had to terminate the study early
clinicaltrials.gov 

Yea, they use to goop it on and shoot it with lasers....now they just goop it on every day for 28 days

Share Recommend | Keep | Reply | Mark as Last Read

To: Mark Buczynski who wrote (9416)8/19/2011 7:05:53 PM
From: TheMaster   of 11958
 
thankfully i haven't stooped!

Share Recommend | Keep | Reply | Mark as Last Read

From: TheMaster8/23/2011 9:54:23 AM
   of 11958
 
"all quite on the Western Front." Then all hell broke loose!

Share Recommend | Keep | Reply | Mark as Last Read

From: TheMaster8/23/2011 3:36:53 PM
   of 11958
 
What's a cancer drug worth? Plenty; minyanville.com 

Share Recommend | Keep | Reply | Mark as Last Read

From: jm2i1238/23/2011 4:01:07 PM
   of 11958
 
any info from company on what price range would be for pv-10?

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (2)

To: jm2i123 who wrote (9421)8/23/2011 4:20:43 PM
From: NTTG2 Recommendations   of 11958
 
Lets hope the company is not spending serious time or money on price point calculations at this early stage of development. Pray that MGT at least has that much common sense.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: NTTG who wrote (9422)8/23/2011 4:24:09 PM
From: TheMaster   of 11958
 
you didnt reply last time, $10,000 right?

Share Recommend | Keep | Reply | Mark as Last Read

To: jm2i123 who wrote (9421)8/23/2011 4:25:59 PM
From: TheMaster   of 11958
 
I believe Rodman's analyst used $19,000 per patient and about a 15% penetration of the mkt. You can pull the report. This had PVCT earning $3/share in the second or third yr on the mkt.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: TheMaster who wrote (9424)8/24/2011 6:27:44 AM
From: NTTG2 Recommendations   of 11958
 
The same analysts who project $3 SP, right? Do they have a relationship with PVCT?

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)
Previous 10 | Next 10 

Copyright © 1995-2013 Knight Sac Media. All rights reserved.